Chemotherapy was found to enhance the amount of PD-L1 on tumor cells, as well as the number of TILs [51]; hence, immune checkpoint inhibitors combined with chemotherapy have shown promising clinical results [52,53]. This evidence concerns the gene CD274 and neoplasm.